Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

475 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Role of KCNK3 Dysfunction in Dasatinib-associated Pulmonary Arterial Hypertension and Endothelial Cell Dysfunction.
Ribeuz HL, Willer AS, Chevalier B, Sancho M, Masson B, Eyries M, Jung V, Guerrera IC, Dutheil M, Jekmek KE, Laubry L, Carpentier G, Perez-Vizcaino F, Tu L, Guignabert C, Chaumais MC, Péchoux C, Humbert M, Hinzpeter A, Mercier O, Capuano V, Montani D, Antigny F. Ribeuz HL, et al. Among authors: chevalier b. Am J Respir Cell Mol Biol. 2024 Jul;71(1):95-109. doi: 10.1165/rcmb.2023-0185OC. Am J Respir Cell Mol Biol. 2024. PMID: 38546978
Design of Crotoxin-Based Peptides with Potentiator Activity Targeting the ΔF508NBD1 Cystic Fibrosis Transmembrane Conductance Regulator.
Ravatin M, Odolczyk N, Servel N, Guijarro JI, Tagat E, Chevalier B, Baatallah N, Corringer PJ, Lukács GL, Edelman A, Zielenkiewicz P, Chambard JM, Hinzpeter A, Faure G. Ravatin M, et al. Among authors: chevalier b. J Mol Biol. 2023 Feb 1;435(3):167929. doi: 10.1016/j.jmb.2022.167929. Epub 2022 Dec 22. J Mol Biol. 2023. PMID: 36566799
Novel gain-of-function mutants identify a critical region within CFTR membrane-spanning domain 2 controlling cAMP-dependent and ATP-independent channel activation.
Castanier S, Elbahnsi A, Chevalier B, Baatallah N, Pranke I, Berri L, Edelman A, Sermet-Gaudelus I, Mornon JP, Callebaut I, Hinzpeter A. Castanier S, et al. Among authors: chevalier b. Cell Mol Life Sci. 2024 Oct 7;81(1):426. doi: 10.1007/s00018-024-05431-9. Cell Mol Life Sci. 2024. PMID: 39373784 Free PMC article.
Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codons.
Pranke I, Bidou L, Martin N, Blanchet S, Hatton A, Karri S, Cornu D, Costes B, Chevalier B, Tondelier D, Girodon E, Coupet M, Edelman A, Fanen P, Namy O, Sermet-Gaudelus I, Hinzpeter A. Pranke I, et al. Among authors: chevalier b. ERJ Open Res. 2018 Feb 23;4(1):00080-2017. doi: 10.1183/23120541.00080-2017. eCollection 2018 Jan. ERJ Open Res. 2018. PMID: 29497617 Free PMC article.
Modulators of CFTR. Updates on clinical development and future directions.
Bardin E, Pastor A, Semeraro M, Golec A, Hayes K, Chevalier B, Berhal F, Prestat G, Hinzpeter A, Gravier-Pelletier C, Pranke I, Sermet-Gaudelus I. Bardin E, et al. Among authors: chevalier b. Eur J Med Chem. 2021 Mar 5;213:113195. doi: 10.1016/j.ejmech.2021.113195. Epub 2021 Jan 16. Eur J Med Chem. 2021. PMID: 33524685 Review.
475 results